Table 3 Multivariable analysis association between progression-free survival (PFS)/overall survival (OS) and IHC staining status of CD8, CD4, and CD68.

From: Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma

  

Hazard ratio

95% CI

p value

PFS

CD8 + 

0.455

0.238

0.868

0.017

CD4 + 

2.009

1.002

4.030

0.049

CD68 + 

0.342

0.149

0.784

0.011

OS

CD8 + 

0.267

0.113

0.631

0.003

CD4 + 

3.571

1.486

8.583

0.004

CD68 + 

0.285

0.085

0.954

0.042